Organovo Holdings, Inc.
NASDAQ Capital MarketTotal Valuation
Organovo Holdings, Inc. carries a market capitalization of 3.67M, placing it among publicly traded companies globally. Its enterprise value stands at -7.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.67M |
| Enterprise Value | -7.21M |
Share Statistics
Organovo Holdings, Inc. currently has 1.80M shares outstanding.
| Shares Outstanding | 1.80M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 21.91, and the price-to-book ratio stands at -0.01.
| PE Ratio | N/A |
| PS Ratio | 21.91 |
| PB Ratio | -0.01 |
| P/TBV Ratio | 0.30 |
| P/FCF Ratio | -0.33 |
| P/OCF Ratio | -0.33 |
Enterprise Valuation
| EV / Sales | 170.99 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Organovo Holdings, Inc. maintains a current ratio of 3.25, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.98, indicating elevated leverage, while an interest coverage ratio of -1,235.00 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.25 |
| Quick Ratio | 3.04 |
| Debt / Equity | 8.98 |
| Debt / EBITDA | -0.08 |
| Interest Coverage | -1,235.00 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -23.70 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 0.73 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.03 |
Taxes
| Income Tax | 2,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Organovo Holdings, Inc.'s stock has declined approximately -84.16149% over the past 52 weeks. The 50-day moving average sits at 3.82, while the 200-day moving average is 5.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | -84.16149% |
| 50-Day Moving Average | 3.82 |
| 200-Day Moving Average | 5.02 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Organovo Holdings, Inc. generated 144,000.00 in revenue and converted that into -2.49M in net income, yielding earnings per share of -1.77. EBITDA reached -12.35M, while operating income came in at -12.62M.
| Revenue | 144,000.00 |
| Gross Profit | 139,000.00 |
| Operating Income | -12.62M |
| Pretax Income | -2.49M |
| Net Income | -2.49M |
| EBITDA | -12.35M |
| EBIT | -12.62M |
| Earnings Per Share (EPS) | -1.77 |
Balance Sheet
Organovo Holdings, Inc. holds 11.31M in cash and equivalents against 942,000.00 in total debt, resulting in a net debt position of -11.31M. Total book value stands at -342.15M, with working capital of 8.39M providing operational flexibility.
| Cash & Cash Equivalents | 11.31M |
| Total Debt | 942,000.00 |
| Net Debt | -11.31M |
| Equity (Book Value) | -342.15M |
| Book Value Per Share | -242.88 |
| Working Capital | 8.39M |
Cash Flow
Organovo Holdings, Inc. produced -9.46M in operating cash flow over the past twelve months. After subtracting -13,000.00 in capital expenditures, free cash flow totaled -9.47M - equivalent to -6.73 per share.
| Operating Cash Flow | -9.46M |
| Capital Expenditures | -13,000.00 |
| Free Cash Flow | -9.47M |
| FCF Per Share | -6.73 |
Margins
Organovo Holdings, Inc. operates with a gross margin of 96.53, reflecting its pricing power and cost economics. The operating margin of -8,761.11 and net profit margin of -1,727.78 provide insight into operational efficiency.
| Gross Margin | 96.53 |
| Operating Margin | -8,761.11 |
| Pretax Margin | -1,726.39 |
| Profit Margin | -1,727.78 |
| EBITDA Margin | -8,576.39 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -280.36 |
| FCF Yield | -299.41 |
Stock Splits
Organovo Holdings, Inc.'s most recent stock split took place on March 21, 2025 with a 12:1 split ratio.
| Last Split Date | 3/21/2025 |
| Split Ratio | 12:1 |
Scores
Organovo Holdings, Inc. posts an Altman Z-Score of -34.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -34.39 |